A dose of only 5 mg prednisolone daily retards radiographic progression in early rheumatoid arthritis - The Low-Dose Prednisolone Trial

Clinical and Experimental Rheumatology

Volumn 29, Issue 5 SUPPL. 68, 2011, Pages

  Wassenberg, S ^a   Rau, R ^b   Zeidler, H ^c  

^a Evangelisches Fach krankenhaus Ratingen   (Germany)

^b Irisweg 5   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Prednisolone; Radiographic progression; Rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PREDNISOLONE;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG SAFETY; HEIJDE SCORE; HUMAN; INTENTION TO TREAT ANALYSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RATINGEN SCORE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SIDE EFFECT; WEIGHT GAIN;

ADMINISTRATION, ORAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; PREDNISOLONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 81155125112     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. A comparison of cortisone and aspirin in the treatment of early cases of rheumatoid arthritis. Joint Committee of the Medical Research Council and Nuffield Foundation. Br Med J 1954; 29: 1223-7.
2. JOINT COMMITTEE OF THE MEDICAL RESEARCH COUNCIL AND NUFFIELD FOUNDATION: A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis. Ann Rheum Dis 1959; 18: 173-88.
3. EMPIRE RHEUMATISM COUNCIL: Multi-center controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis. Results up to one year. Ann Rheum Dis 1955; 14: 353-70.
4. EMPIRE RHEUMATISM COUNCIL: Multi-center controlled trial comparing cortisone acetate and acetyl salicylic acid in the long-term treatment of rheumatoid arthritis. Results of three years treatment. Ann Rheum Dis 1957; 16: 277-89
5. SOKKA T, PINCUS T: Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients. J Rheumatol 2002; 29: 2521-4. (Pubitemid 35416955)
6. THIEHLE K, BUTTGEREIT F, HUSCHER D, ZINK A for the GERMAN COLLABORATIVE ARTHRITIS CENTRES: Current Use of Glucocorticoids in Patients with Rheumatoid Arthritis in Germany. Arthritis Rheum 2005; 53: 740-7. (Pubitemid 41463840)
7. WASSENBERG S, RAU R, STEINFELD P, ZEIDLER H for THE LOW-DOSE PREDNISOLONE STUDY GROUP: Very Low-Dose Prednisolone in Early Rheumatoid Arthritis Retards Radiographic Progression Over Two Years - A Multicenter, Double-Blind, Placebo-Controlled Trial. Arthritis Rheum 2005; 52: 3371-80. (Pubitemid 41612203)
8. RAU R, HERBORN G, MENNINGER H, BLECHSCHMIDT J: Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 month data of a double-blind parallel study of 174 patients. Br J Rheumatol 1997; 36: 345-52.
9. BRUYNESTEYN K, VAN DER HEIJDE D, BOERS M et al.: Detecting radiological changes in rheumatoid arthritis that are considered important by clinical experts: Influence of reading with or without known sequence. J Rheumatol 2002; 29: 2306-12. (Pubitemid 35266020)
10. RAU R, WASSENBERG S, HERBORN G, STUCKI G, GEBLER A: A new method of scoring radiographic change in rheumatoid arthritis. J Rheumatol 1998; 25: 2094-107. (Pubitemid 28505854)
11. VAN DER HEIJDE DM, VAN RIEL PM, NUVERZWART IH, GRIBNAU FW, VAN DER PUTTE LBA: Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989; 8646: 1036-8. (Pubitemid 19123055)
12. THOMPSON PW: Articular indices of joint inflammation in rheumatoid arthritis. Arthritis Rheum 1987;30:618-23.
13. RASPE H-H, KINDEL P, VESTERLING K, KOHLMANN T: Die Entwicklung der Funktionskapazität und der Schmerzintensität von 81 cP-Patienten unter einer Behandlung mit Azulfidine RA oder Aurothioglucose: Vorläufige statistische Auswertung der multizentrischen deutschen Studie zur Behandlung der chronischen Polyarthritis mit Azulfidine RA. Z Rheumatol 1987; 46: 71-5. (Pubitemid 17119686)
14. HAUTZINGER M, BAILER M: Allgemeine Depressionsskala (ADS) Weinheim: Beltz 1993.
15. PINALS RS, MASI AT, LARSEN RA and THE SUBCOMMITTEE FOR CRITERI AH OF REMISSION IN RHEUMATOID ARTHRITIS OF THE AMERICAN RHEUMATISM ASSOCIATION DIAGNOSTIC AND THERAPEUTIC CRITERIA COMMITTE: Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981; 24: 1308-15. (Pubitemid 11022943)
16. KIRWAN JR. and the ARTHRITIS AND RHEUMATISM COUNCIL LOW-DOSE GLUCOCORTICOID STUDY GROUP: The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995; 333: 142-6.
17. VAN EVERDINGEN AA, JACOBS JWG, SIEWERTSZ VAN REESEMA DR, BIJLSMA JWJ: Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties and side effects. A randomized, double blind, placebo-controlled clinical trial. Ann Intern Med 2002; 136: 1-12. (Pubitemid 34038692)
18. SVENSSON B, BOONEN A, ALBERTSSON K, VAN DER HEIJDE D, KELLER C HAFSTRÖM I for the BARFOT STUDY GROUP: Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: A two-year randomized trial. Arthritis Rheum 2005; 52: 3360-70. (Pubitemid 41612202)
19. HARRIS ED JR., EMKEY RD, NICHOLS JE, NEWBERG A: Low dose prednisone therapy in rheumatoid arthritis: a double blind study. J Rheumatol 1983; 10: 713-21. (Pubitemid 14176085)
20. PAULUS HE, DIPRIME D, SANDA M et al., for THE LONG-TERM ETODOLAC STUDY INVESTIGATORS: Progression of radiographic joint erosion during low dose corticosteroid treatment of rheumatoid arthritis. J Rheumatol 2000; 27: 1632-7. (Pubitemid 30462803)
21. HANSEN M, PODENPHANT J, FLORESCU A et al.: A randomized trial of differentiated prednisolone treatment in active rheumatoid arthritis: clinical benefits and skeletal side effects. Ann Rheum Dis 1999; 58: 713-8. (Pubitemid 29517259)
22. BATHON JM, MARTIN RW, FLEISCHMANN RM et al.: A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 2000; 343: 1586-93. (Pubitemid 32162981)
23. VAN GESTEL AM, LAAN RFJM, HAAGSMA CL, VAN DE PUTTE LBA, VAN RIEL PLCM: Low dose oral steroids as bridge therapy in rheumatoid arthritis patients starting with parenteral gold. A randomized double blind plcebo-controlled trial. Br J Rheumatol 1995; 34: 347-51.
24. HOES JN, JACOBS JWG, BOERS M et al.: EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 2007; 66: 1560-7. (Pubitemid 350205441)
25. DA SILVA JA, JACOBS JW, KIRWAN JR et al.: Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis 2006; 65: 285-93. (Pubitemid 43268214)
26. MCDOUGALL R, SIBLEY J, HAGA M, RUSSELL A: Outcome in patients with rheumatoid arthritis receiving prednisone compared to matched controls. J Rheumatol 1994; 21: 1207-23.
27. SAAG KG, KOEHNKE R, CALDWELL JR et al.: Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 1994; 96: 115-23. (Pubitemid 24070529)
28. VAN STAA TP, LEUFKENS HGM, ABENHEIM L, ZHANG B, COOPER C: Oral corticoids and fracture risk: relationship to daily and cumulative doses. Rheumatology 2000; 39: 1383-9. (Pubitemid 32045866)
29. COHEN S, LEVY RM, KELLER M et al.: Risedronate therapy prevents corticosteroid-induced bone loss: a twelve month, multicenter, randomized, double-blind, plcebocontrolled, parallel-group study. Arthritis Rheum 1999; 42:2309-18.